There is a conventional way to think about Oral Films: as a formulation alternative to tablets. Easier to swallow, faster to dissolve, better adherence in certain patient populations. Useful, but secondary to the molecule. A recently announced licensing agreement in the Oral Films space challenges that framing. The deal combines [...]